Literature DB >> 25801217

Advanced oxidation protein products decrease the expression of calcium transport channels in small intestinal epithelium via the p44/42 MAPK signaling pathway.

Peiqun Wu1, Fang Xie1, Minmin Xue1, Xiaoping Xu1, Shuying He1, Minyi Lin1, Lan Bai2.   

Abstract

Advanced oxidation protein products (AOPPs), novel protein markers of oxidative damage, accumulate in the plasma of patients with inflammatory bowel disease (IBD). Osteoporosis, which is closely related to the regulation of intestinal calcium transport channels (CTCs), is a prevalent extraintestinal complication of IBD and is associated with oxidative stress. However, the underlying mechanisms are unknown. The present study aimed to verify whether AOPPs inhibit CTCs in the small intestinal epithelium and to identify the underlying mechanisms that may contribute to IBD-associated osteoporosis. Normal Sprague-Dawley rats were treated with AOPP-modified rat serum albumin. The calcium ion level in serum was not significantly altered, while the duodenal expression of CTCs (e.g. transient receptor potential vanilloid [TRPV6], calbindin-D9k [CaBP-D9k], plasma membrane Ca(2+)-ATPase 1 [PMCA1], and Na(+)/Ca(2+) exchanger 1 [NCX1]) were decreased. In contrast, the levels of the related hormones that regulate calcium absorption including parathyroid hormone (PTH), 25-(OH)D₃, and 1,25-(OH)₂D₃ were increased, although the trend toward an increase in PTH levels was not significant. In order to further investigate the effects of AOPP exposure, we also evaluated the expression of CTCs (including the voltage-dependent L-type calcium channel [CaV1.3], TRPV6, CaBP-D9k, PMCA1, and NCX1) in cultured human colorectal adenocarcinoma cells (Caco-2). The expression levels of total CTC protein and mRNA, except for CaV1.3, were significantly down-regulated in a concentration- and time-dependent manner. Moreover, phosphorylation of p44/42 mitogen-activated protein kinase (MAPK) was observed in vivo and in vitro. The p44/42 inhibitor U0126 reversed the down-regulation of CTCs induced by AOPPs in the Caco-2 monolayer. Our results indicate that AOPPs down-regulate the expression of CTCs through p44/42 MAPK signaling mechanisms in the small intestinal epithelium. These data provide new insights regarding the molecular basis of AOPP-induced reductions in intestinal CTCs, and are relevant to understanding the mechanisms of IBD-associated osteoporosis. Further studies are needed to explore these mechanisms in greater detail.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Advanced oxidation protein products; Calcium; Calcium transport channels; Intestinal epithelium; Mitogen-activated protein kinase

Mesh:

Substances:

Year:  2015        PMID: 25801217     DOI: 10.1016/j.ejcb.2015.02.002

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  5 in total

Review 1.  Regulation of Intestinal Glucose Absorption by Ion Channels and Transporters.

Authors:  Lihong Chen; Biguang Tuo; Hui Dong
Journal:  Nutrients       Date:  2016-01-14       Impact factor: 5.717

Review 2.  Oxidative stress, antioxidants and intestinal calcium absorption.

Authors:  Gabriela Diaz de Barboza; Solange Guizzardi; Luciana Moine; Nori Tolosa de Talamoni
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

3.  Effect of parathyroid hormone on cardiac function in rats with cardiomyopathy.

Authors:  Gang-Yong Wu; Ting Wu; Bai-Da Xu; Yi-Cheng Shi; Zhi-Yuan Cheng; Xiao Zhang; Xiao Wang; Gang-Jun Zong
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

4.  Plasma level of advanced oxidation protein products as a novel biomarker of acute lung injury following cardiac surgery.

Authors:  Songlin Du; Jun Ai; Xiangzhen Zeng; Jun Wan; Xu Wu; Jianxing He
Journal:  Springerplus       Date:  2016-02-29

Review 5.  Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases.

Authors:  Alicja Derkacz; Pawel Olczyk; Katarzyna Komosinska-Vassev
Journal:  Dis Markers       Date:  2018-06-11       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.